Several studies have demonstrated that MDM2 is a new therapeutic option in colon cancer treatment51 as both the inhibitor and anti-sense oligonucleotide of MDM2 have anti-tumor activity by inhibiting growth and proliferation of colon cancer cells52,53. The gene discussed is MDM2; the disease is digestive system cancer.